SCHEMBL4011275

SCHEMBL4011275

COc1cccc(-c2cc(C(=O)N[C@@H](CC(C)C)C(O)I)cnc2N2CCCC2)c1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CTSA P10619 2/20 0.44
▸ DGAT2 Q96PD7 1/20 0.42
▸ ROCK1 Q13464 8/20 0.41
▸ PRKACA P17612 1/20 0.41
▸ GSK3A P49840 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ PRKX P51817 1/20 0.41
▸ PRKCQ Q04759 1/20 0.41
▸ MST1R Q04912 1/20 0.41
▸ ABL1 P00519 2/20 0.40
▸ P2RY12 Q9H244 1/20 0.40
▸ HPGDS O60760 1/20 0.39
▸ ROCK2 O75116 8/20 0.39
▸ PRKG1 Q13976 1/20 0.39
▸ AVPR1B P47901 1/20 0.39
▸ JAK2 O60674 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4014598 0.91 ABL1 (0.47) CTSAABL1HPGDS
SCHEMBL4012343 0.88 CNR2 (0.44) CTSAABL1P2RY12AVPR1B
SCHEMBL2701916 0.86 CTSA (0.45) CTSADGAT2ROCK1PRKACAGSK3A
SCHEMBL2704327 0.86 CTSA (0.45) CTSADGAT2ROCK1PRKACAGSK3A
SCHEMBL4012466 0.83 ABL1 (0.40) ABL1P2RY12
SCHEMBL4012349 0.83 ABL1 (0.40) ABL1P2RY12
SCHEMBL4012642 0.82 ABL1 (0.39) ABL1P2RY12
SCHEMBL4016284 0.82 ABL1 (0.39) ABL1P2RY12
SCHEMBL4013441 0.81 CCR1 (0.40) CTSAROCK1ABL1P2RY12ROCK2
SCHEMBL2703783 0.77 ABL1 (0.49) CTSAABL1HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074096-A1 3-PYRIDINECARBOXAMIDE AND 2-PYRAZINECARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS F.HOFFMANN-LA ROCHE AG (CH) 2009-07-01 — — EP disclosed
WO-2008040651-A1 3-PYRIDINECARBOXAMIDE AND 2-PYRAZINECARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2008-04-10 — — WO disclosed
Send feedback